WuXi PharmaTech, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, filed for an IPO Tuesday with the SEC. The firm plans to offer 13.2 million ADSs, including 3.2 million from selling shareholders, at a price range of $11 to $13 per ADS. The firm filed to be listed on the NYSE under the ticker "WX." Credit Suisse and JP Morgan are the lead managers on the deal.
